Determination of cytosine arabinoside in human plasma by gas chromatography with a nitrogen-sensitive detector and by gas chromatography—mass spectrometry
Authors:
- John BoutagyJBJohn Boutagy
- David J. HarveyDHDavid J. Harvey
- 1 September 1978
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 146 (2) , 283-296
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Analysis of cytosine arabinoside and related pyrimidine nucleosides by gas chromatography and gas chromatography-mass spectrometryJournal of Chromatography A, 1978
- Pharmacokinetics of cytosine arabinoside in acute myeloid leukemiaClinical Pharmacology & Therapeutics, 1977
- A sensitive bio-assay for pharmacokinetic studies of cytosine arabinoside in manEuropean Journal of Cancer (1965), 1976
- Plasma half-life of cytosine arabinoside in patients with leukaemia—the effect of uridineEuropean Journal of Cancer (1965), 1975
- Differential Analysis of Cyclocytidine, 1-β-D-Arabinofuranosylcytosine, and 1-β-D-Arabinofuranosyluracil by Ultraviolet Spectophotometry2JNCI: Journal of the National Cancer Institute, 1974
- Application of gas chromatography—chemical ionization mass fragmentography in thed evaluation of bases and nucleoside analogues used in cancer chemotherapyJournal of Chromatography A, 1974
- Pharmacokinetics of 1-β-d-arabinofuranosylcytosine (Ara-C) deamination in several speciesBiochemical Pharmacology, 1973
- Clinical pharmacology of l‐β‐D‐arabinofuranosyl cytosineClinical Pharmacology & Therapeutics, 1971
- Biochemical and pharmacological studies with 1-β-d-arabinofuranosylcytosine in manBiochemical Pharmacology, 1966